There has been grave concern for the rapidly increasing prevalence of prediabetes as an intermediate metabolic state from normoglycemia (NG) to diabetes mellitus (DM). 1 Prediabetes is defined as one of categories comprising impaired fasting glucose (IFG), impaired glucose tolerance (IGT) identified by oral glucose tolerance test and glycated hemoglobin (HbA1c) above specific level, in which each phenotype can overlap. 2 The population-based US National Health and Nutrition Examination Survey (NHANES) indicated that 35% of US adults over age of 20 years and 50% of those over age of 65 years had prediabetes in 2005-2008 based on fasting glucose or HbA1c levels. 3 When this prevalence was applied to the entire US population in 2010, it was estimated that 79 million adults had prediabetes. 3 Moreover, the number of adults with IGT is increasing globally, and expected to reach 472 million by 2030 more predominantly in South-East Asia and the Western Pacific Region. 4 Although the prevalence of prediabetes has markedly increased by increasing obesity, nutritional transition to high fat and calorie intake and urbanization, the predicted prevalence may be underestimated due to lack of awareness in developing countries.
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The recent meta-analysis investigating 53 prospective studies with 1,611,339 individuals suggested that the risk of cardiovascular disease (CVD) significantly increased even at the state of prediabetes. 5 Additionally, there has been substantial evidence that links prediabetes to end organ damage on kidney and eye conventionally recognized to be complications of overt DM. 6 The pathophysiology of these adverse health outcomes are considerably related to vasculopathy, and thus, it is expected that the coexistence of hypertension with prediabetes can profoundly increase the risk of adverse health outcome. Nonetheless, there is still limited information about the risk of hypertension in individuals with prediabetes. Given that hypertension is two times more common in individuals with DM than those without DM, 7 it is inferred that individuals with prediabetes have the higher risk of hypertension than individuals without prediabetes. Additionally, the risk of coronary heart disease was found to be different even among the same category of prediabetes, 8 which suggests the differing risk of hypertension according to the phenotypes of prediabetes.
To identify the influence of prediabetes on the development of hypertension, using data from nondiabetic general Korean population, we examined the risk of hypertension in individuals with prediabetes. Subgroup analysis for each category of prediabetes was conducted to compare the risk of hypertension among each category. Additionally, considering the feature of prediabetes as an intermediate metabolic state, we evaluated the risk of hypertension according to the change of glycemic state in nondiabetic population.
METHODS

Study design and participants
All subjects were participants of the Korean Genome and Epidemiology Study (KoGES) Ansan and Ansung study, which was a population-based, epidemiology study of rural and urban community in South Korea. Detailed methods and study population of KoGES were described in a previous study. 9 The baseline survey of KoGES Ansan and Ansung study was completed in 2001-2002, and follow-up survey was conducted every 2 years for 10 years. Initially, a total of 10,038 participants aged 40-69 participated in the study. Five thousand one hundred eight subjects were recruited by cluster-sampling method stratified by age, sex, and residential district in Ansung community, and 5,012 subjects were selected by random sampling method in Ansan. Out of the 10,038 participants, we initially excluded subjects with baseline hypertension (n = 3,248), subjects without data about blood pressure (BP) (n = 15) and subjects with baseline DM (n = 667). Among remaining 6,108 participants, we further excluded 695 subjects who were lost to follow-up or incomplete in follow-up data during a 10 years' follow-up period. Finally, 5,413 participants were enrolled in the present study (Figure 1 ). All subjects voluntarily participated in the study, and informed consent was obtained in all cases. Ethics approvals for the study protocol and analysis of the data were obtained from the institutional review board of Kangbuk Samsung Hospital.
Clinical and biochemical measurements
Study data included medical history and sociodemographic information provided by a self-administered questionnaire, anthropometric measurements and laboratory biochemical measurements. All study participants were also asked to respond to a health-related behavior questionnaire, which included the topics of alcohol consumption, smoking, and exercise. Physical activity divided two categories; regular exercise (≥90 minutes exercise per week, at least moderate intensity) or inactive group. The questions about alcohol intake included the frequency of alcohol intake on a weekly basis and the amount of alcohol consumption on a daily basis (g/day). Smoking status was divided into three categories comprising never, former, and current smoker. DM was defined as at least one of four conditions including fasting glucose ≥126 mg/dl, HbA1c level ≥6.5%, 2 hour post-load glucose (2 hr-PG) ≥200 mg/dl on oral glucose tolerance test and participants who have ever been diagnosed with DM. IGT was defined in the level of 2 hr-PG from 140 to 199 mg/ dl, and IFG was defined in the level of fasting glucose from 100 to 125 mg/dl. 2 Participants with at least one of three conditions including IGT, IFG, and HbA1c ≥5.7% were classified as prediabetes group. The aforementioned diagnostic criteria for prediabetes and DM were identically used in defining the incidence cases of prediabetes and DM during follow-up. NG was defined in participants with all of three conditions including 2 hr-PG <140 mg/dl, fasting glucose <100 mg/dl, and HbA1c <5.7%.
The baseline hypertension was defined in the participants with the past history of hypertension or measured BP ≥140/90 mm Hg at initial examination. All study participants were normotensive at baseline, and incidence of hypertension was defined in participants with measured BP ≥140/90 mm Hg or newly diagnosed hypertension during follow-up.
BP was measured on both arms in sitting position after at least 10 minutes resting. There was a 5-minutes resting period between each measurement. The arithmetic mean value of the BP was used to define the systolic and diastolic BP. Height and weight of all participants were measured to calculate body mass index (BMI) (kg/m 2 ). After fasting overnight for 12 hours, the plasma concentrations of glucose, total cholesterol, triglyceride, and HDL cholesterol were measured enzymatically, using a 747 Chemistry Analyzer (Hitachi, Tokyo, Japan). In the baseline and follow-up examinations, oral glucose tolerance test was performed in all study participants. The concentration of fasting plasma insulin was determined by a radioimmunoassay kit (Linco Research, St. Charles, MO), and HbA1c was measured by high-performance liquid chromatography (VARIANT II; Bio-Rad Laboratories, Hercules, CA). The concentration of C-reactive protein (CRP) was measured by Turbidimetric Immuno Assay (HITACHI Automatic Analyzer 7600 and ADVIA 1650; Bayer Diagnostics, Tarrytown, NY). Insulin resistance (IR) was represented by homeostasis model assessmentinsulin resistance (HOMA-IR), using following formula: HOMA-IR = fasting serum insulin (uU/ml) × fasting serum glucose (mg/dl)/405.[AU: Please check the unit "uU/ml. "]
Statistical analysis
All participants were categorized into two groups according to the presence of prediabetes. Data are presented as means ± standard deviation within groups for continuous variables and as proportions for categorical variables. Main clinical characteristics and biochemical parameters between two groups were compared using independent t-test for continuous variables and chi-square test for categorical variables.
To assess long-term risk for hypertension, the crude and multivariate-adjusted hazard ratios (HRs) with their 95% confidence intervals (CI) were estimated by the use of the Cox proportional hazards model. The covariates of the adjusted model are age, sex, study area (Ansan or Ansung), regular exercise, BMI, smoking, total cholesterol, CRP and alcohol intake. The incidence cases of hypertension and incidence density (incidence cases per 1,000 person-years) were calculated in each study group. The crude and adjusted HRs for hypertension was obtained not only in the prediabetes group but also in each category of prediabetes including IGT, IFG, and HbA1c ≥5.7%.
Subgroup analysis was conducted in subdivided HbA1c with <5.7%, 5.7-5.9%, and 6.0-6.4% and 2-hr PG with <140, 140-169, and 170-199 mg/dl. However, subgroup analysis in IFG couldn't be conducted due to the small number of participants with the identifiable data for fasting glucose.
The change of glycemic state was defined by whether baseline glycemic state remained or progressed during follow-up in each baseline NG and prediabetes group. Baseline NG group was categorized into three groups of remaining in NG (NG → NG), progressing into prediabetes (NG → prediabetes) and DM (NG → DM). Baseline prediabetes group was categorized into two groups of remaining in prediabetes (prediabetes → prediabetes) and progressing into DM (prediabetes → DM).
A value of P < 0.05 was considered statistically significant in analysis, and statistical analyses were performed using R 3.4.3 (R Foundation for Statistical Computing, Vienna, Austria).
RESULT Baseline clinical characteristics of the study population
A total of 5,413 participants were enrolled (2,497 men and 2,916 women) in the study. The mean age of the study participants was 50.2 ± 8.4 years, and the prevalence of baseline prediabetes was 19.7%. The final follow-up examination was done in 2011-2012. During 10 years of follow-up, hypertension developed in 1,528 participants with incidence of 28.2% (803 in NG group and 725 in prediabetes group). The overall incidence case is 35.1 cases per 1,000 person-years in NG, and 44.0 cases per 1,000 person-years in prediabetes. The baseline clinical characteristics of study participants are presented in Table 1 . Compared with the NG group, prediabetes group had the higher fasting glucose, 2 hr-PG, HbA1c, total cholesterol, HDL-cholesterol, triglyceride, age, BMI, CRP values, systolic and diastolic BP. The incidence cases of prediabetes in NG group was 1,703 (55.1%), and the incidence cases of DM was 225 (7.3%) in NG group and 636 (27.4%) in prediabetes group. Adjusted for age, sex, area (Ansan or Ansung), regular exercise, BMI, smoking, CRP, total cholesterol, average alcohol use. Incidence density: incidence cases per 1,000 person-year. Abbreviations: BMI, body mass index; CRP, C-reactive protein. Continuous variables are expressed as mean (±SD), and categorical variables are expressed as number (percentage (%)). Abbreviations: NG, normoglycemia; HDL, high-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; 2-hr PG, 2-hour plasma glucose; 1-hr PG, 1-hour plasma glucose; HOMA-IR, homeostasis model assessment-insulin resistance; T2DM, type 2 diabetes mellitus.
When prediabetic ranges of HbA1c and 2 hr-PG were stratified into 3 subgroups, only 2 hr-PG subgroup of 170-199mg/dL had the statistically significant adjusted HRs with 95% CI for hypertension [1.37 (1.09-1.73)] ( Table 3) .
The progression of glycemic state was significantly associated with the increased risk of hypertension ( 
DISCUSSION
Despite the accumulating evidence suggesting the significant association between prediabetes and CVD, there have been inconsistent results on the contribution of each category of prediabetes to the development of CVD. In a systematic review investigating the studies between 1997 and 2008, IFG and IGT were associated with the only slightly elevated risk for CVD. 10 A cohort study for 652,901 Korean men observed that the increased risk for myocardial infarction was identified only in the level of fasting glucose higher than the diagnostic threshold of DM. 11 This argument was prominent in macrovascular disease including coronary heart disease, but there is less certainty with respect to the influence of prediabetes on cerebrovascular disease and aortic aneurysm. 12 Previous studies highlighted the role of hypertension in markedly increasing the risk of CVD in individuals with prediabetes. In a 12 years' longitudinal observation for a total of 2,629 Strong Heart Study participants free from hypertension and CVD at baseline, IFG or IGT alone did not promote the risk of developing CVD, but combined presence of prehypertension with IFG or IGT increased the risk of CVD by about two fold, compared with NG in normotensive subjects. 13 Additionally, a recent study for 2,132 Chinese demonstrated that IFG or IGT alone was not associated with the elevated risk of CVD, but when it occurred in the hypertensive subjects, the risk for CVD increased by 2.41 fold. 14 These studies suggest that hypertension mediate the causative relationship between prediabetes and CVD. Thus, it would be clinically meaningful to assess the risk of Adjusted for age, sex, area (Ansan or Ansung), regular exercise, BMI, smoking, CRP, total cholesterol, average alcohol use. Incidence density: incidence cases per 1,000 person-year. Abbreviations: BMI: body mass index; CRP: C-reactive protein. Adjusted for age, sex, area (Ansan or Ansung), regular exercise, BMI, smoking, CRP, total cholesterol, average alcohol use. Incidence density: incidence cases per 1,000 person-year. Abbreviations: NG, normoglycemia; DM, diabetes mellitus; BMI, body mass index; CRP, c-reactive protein.
hypertension in individuals with prediabetes. Nonetheless, evidence is less clear regarding the influence of prediabetes on the development of hypertension. We were to test whether the risk of hypertension increases even at the state of prediabetes, identifying the difference in the risk of hypertension among the categories of prediabetes. In the present study, we observed the difference in the incidence of hypertension between prediabetes and NG for 10 years' follow-up. However, after adjusting for covariates including two important risk factors for hypertension, age and BMI, this finding didn't connect to the statistically significant difference in the incidental risk of hypertension. Although HbA1c ≥5.7% and 2 hr-PG ≥140 mg/dl were marginally associated with the risk of hypertension, the magnitude of association was too weak to assure the substantive increase of long-term risk of hypertension in prediabetes. These findings are inconsistent with previous reports indicating the significant relationship between DM and hypertension. In the US population, hypertension occurs in 50-80% of patients with type 2 DM, 15 and Cardiovascular Risk Factor Prevalence Study in Hong Kong demonstrated that only 42% of people with DM had normal blood pressure. 16 This disagreement may be explained by the clinical features of our study participants and factors determining the influence of dysglycemia on the pathogenesis of hypertension. Compared with the incidence of Koreans with same age, our study participants had the relatively low incidence of hypertension (23.8%) for 10 years' follow-up. In a previous community based health study for Koreans, the crude 5-year incidence of hypertension was 26.7% (23.0% in men, and 28.8% in women) and the incidence of hypertension increased with age, and prehypertensive individuals were twice as likely to develop hypertension as the normotensive individuals. 17 In the present study, both NG group and prdiabetes group had the mean BMI less than 25 kg/m 2 and SBP and DBP lower than diagnostic cut-off of prehypertension. The relatively low baseline BMI and BP can contribute to the lower incidence of hypertension, which might attenuate the influence of prediabetes on the development of hypertension. Additionally, while microvascular risk increases in glycemic levels within the nondiabetic range, 18 macrovascular risk in prediabetes was unclear. This is probably because larger vessels need the relatively longer exposure to the high level of insulin and blood glucose or other comorbidities like obesity and dyslipidemia to induce the vascular damage. Although both macro and microvasular alteration are significant pathophysiology of hypertension, damage in large vessels seems more closely related to the clinical manifestation of hypertension. Thus, it is postulated that promoting hypertension needs the long-term adverse influence of hyperglycemia close to the diagnostic range of DM with accompanied metabolic derangements.
Prediabetes is an intermediate metabolic state from NG to overt DM, 2 but contains broad spectrum within each category. Despite the association between each category of prediabetes and cardiometabolic risk, there must be the distinction of the cardiometabolic risk within the same category of prediabetes. Previous studies have demonstrated that the elevated fasting glucose, HbA1c and 2-hour postchallenge glucose within each category of prediabetes were significantly associated with the increased risk for atherosclerosis, DM, and CVD. [19] [20] [21] [22] We stratified the spectrum of HbA1c and 2 hr-PG within each category of prediabetes and conducted subgroup analysis to compare the risk of hypertension among them. Within each stratified subgroup, only group with 2 hr-PG of 170-199 mg/dl had the significantly increased risk of hypertension. This finding suggest that the risk of hypertension substantially increases in the long-term exposure to hyperglycemia impending to the diagnostic threshold of DM.
Our results can be epidemiological evidence indicating the adverse influence of progression of glycemic state on the development of hypertension. In our study, progression of glycemic state during follow-up was significantly associated with the increased risk of hypertension. Remaining NG had the lowest risk of hypertension, and progression from NG to DM had the greater risk of hypertension than progression into prediabetes. Also in prediabetes group, progression to DM significantly increased the risk of hypertension. The aggravation of IR may be an underlying mechanism. Glycemic state is dynamic parameter and depends on IR. Progression of glycemic state reflects the aggravation of IR, which has an adverse impact on circulatory system. Previous studies have demonstrated that IR and compensatory hyperinsulinemia increase the systemic sympathetic tone, accelerates tubular reabsorption of sodium and water, [23] [24] [25] and promote the secretion of proinflammatory cytokines closely linking to vasculoendothelial dysfunction and atherosclerosis. [26] [27] [28] Our findings suggest that the development of hypertension is more influenced by the progression of glycemic state than the glycemic state at specific time. Thus, it is postulated that maintaining stable glycemic state is important in preventing hypertension in nondiabetic population.
Although we couldn't identify the profoundly increased risk of hypertension in prediabetes, our findings may provide the significant information in assessing the risk of hypertension in nondiabetic glycemic states including prediabetes. The risk of hypertension in prediabetes may be moderated by the severity and duration of prediabetes and accompanied metabolic conditions like degree of obesity. Additionally, the progression of glycemic state may be more powerful determinant on hypertension than the baseline glycemic state, which highlights the importance of glycemic control even in nondiabetic range.
Our study should be viewed on the investigation for the modest number of middle-aged Koreans. Thus, our results are not likely to be extrapolated into other age and ethnic groups. It guarantees the necessity of further studies for a large number of nationwide population with a broad age range.
In conclusion, prediabetes showed the weak association with the long-term risk of hypertension. However, the prediabetic range of 2-hr plasma glucose close to diagnostic threshold of DM was strongly associated with the increased risk of hypertension. In particular, the development of hypertension was more significantly influenced by the progression of glycemic state than the baseline glycemic state. These findings suggest that the elevation of BP is induced by the long-term exposure of hyperglycemia close to the diagnostic range of DM and the aggravation of IR. Further studies should be conducted to identify whether the stable management of glycemic state practically reduces the risk of hypertension.
